Completed
Phase 2
Age: 21Years - 55Years
All Genders
ID00000318
Buprenorphine Maintenance Dose Schedule and Treatment Setting Pilot
Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-12
202
Participants Needed
1
Research Sites
178 weeks
Total Duration
On this page
Sponsors
N
National Institute on Drug Abuse (NIDA)
Lead Sponsor
Y
Yale University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.
CONDITIONS
Brief Title
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
Who Can Participate
Age: 21Years - 55Years
All Genders
Eligibility Criteria
Please contact site for information.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here